We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Molecular Signals from Neighboring Dendritic Cells Drive Leukemia Growth

By LabMedica International staff writers
Posted on 22 Feb 2016
Print article
Image: T-cell acute lymphoblastic leukemia (T-ALL), a cancer that strikes primarily in childhood, can only survive and grow when sent a signal from neighboring cells called dendritic cells (shown in green) in the tumor\'s near environment (Photo courtesy of the University of Texas, Austin).
Image: T-cell acute lymphoblastic leukemia (T-ALL), a cancer that strikes primarily in childhood, can only survive and grow when sent a signal from neighboring cells called dendritic cells (shown in green) in the tumor\'s near environment (Photo courtesy of the University of Texas, Austin).
Noncancerous cells in the immediate tumor microenvironment supply signals that drive T-cell acute lymphoblastic leukemia (T-ALL) growth, and may become attractive therapeutic targets to control the disease.

T-ALL cells require signals derived from noncancerous cells to survive. Although many studies have identified alterations in signaling pathways that promote T-ALL growth, the identity of endogenous stromal cells and their associated signals in the tumor microenvironment that support T-ALL remains unknown.

In order to identify the cells that provide growth signals to T-ALL, investigators at the University of Texas (Austin, USA) examined the thymic tumor microenvironments in multiple murine T-ALL models and in human patient samples.

They reported in the February 9, 2016, online edition of the journal Proceedings of the National Academy of Sciences of the United States of America (PNAS) that systematic evaluation of the functional capacity of tumor-associated stromal cells revealed that myeloid cells, primarily dendritic cells (DCs), were necessary and sufficient to support T-ALL survival. DCs supported T-ALL growth both in primary thymic tumors and at secondary tumor sites.

To identify a molecular mechanism by which DCs supported T-ALL growth, the investigators performed gene expression (transcriptome) profiling. Results of these studies revealed up-regulation of platelet-derived growth factor receptor beta (Pdgfrb) and insulin-like growth factor I receptor (Igf1r) on T-ALL cells, with concomitant expression of their ligands by tumor-associated DCs. Both Pdgfrb and Igf1r were activated in T-ALL cell cultures. Co-culture with tumor-associated, but not normal thymic DCs, sustained IGF1R activation. Furthermore, IGF1R signaling was necessary for DC-mediated T-ALL survival.

"It is only more recently that people have really appreciated that tumors are complex organs in and of themselves with all of the heterogenous cell types that can talk to each other and promote each other's survival and proliferation," said senior author Dr. Lauren Ehrlich, assistant professor of molecular biosciences at the University of Texas.

The current paper provides the first evidence that endogenous tumor-associated DCs supply signals driving T-ALL growth, and implicate tumor-associated DCs and their mitogenic signals as attractive therapeutic targets. "If we can find directed therapies to more specifically target the tumors without being overly toxic to the person, that would obviously be much better," said Dr. Ehrlich.

Related Links:

University of Texas


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Clinical Chemistry

view channel
Image: Reaching speeds up to 6,000 RPM, this centrifuge forms the basis for a new type of inexpensive, POC biomedical test (Photo courtesy of Duke University)

POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection

Exosomes, tiny cellular bioparticles carrying a specific set of proteins, lipids, and genetic materials, play a crucial role in cell communication and hold promise for non-invasive diagnostics.... Read more

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.